Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX

被引:71
作者
Cheng, Congsheng [1 ,2 ]
Dong, Jie [1 ]
Yao, Lihong
Chen, Aijun [2 ]
Jia, Runqing [2 ]
Huan, Lifang [2 ]
Guo, Jianqlang [2 ]
Shu, Yuelong [1 ]
Zhang, Zhiqing [2 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 100052, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing 100052, Peoples R China
基金
中国国家自然科学基金;
关键词
influenza virus; H5N1; SELEX; DNA aptamer; antiviral activity;
D O I
10.1016/j.bbrc.2007.11.183
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New therapeutics are urgently needed for the treatment of pandemic influenza caused by H5N1 influenza virus mutants. Aptamer was a promising candidate for treatment and prophylaxis of influenza virus infections. In this study, systemic evolution of ligands through exponential enrichment (SELEX) was used to screen DNA aptamers targeted to recombinant HA1 proteins of the H5N1 influenza virus. After 11 rounds of selection, DNA aptamers that bind to the HA1 protein were isolated and shown to have different binding capacities. Among them, aptamer 10 had the strongest binding to the HA1 protein, and had an inhibitory effect on H5N1 influenza virus, as shown 9 by the hemagglutinin and MTT assays. These results should aid the development of new drugs for the prevention and control of influenza virus infections. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:670 / 674
页数:5
相关论文
共 18 条
[1]   Current concepts - Avian influenza A (H5N1) infection in humans [J].
Beigel, H ;
Farrar, H ;
Han, AM ;
Hayden, FG ;
Hyer, R ;
de Jong, MD ;
Lochindarat, S ;
Tien, NTK ;
Hien, NT ;
Hien, TT ;
Nicoll, A ;
Touch, S ;
Yuen, KY .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1374-1385
[2]   A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema [J].
Cunningham, ET Jr ;
Adamis, AP ;
Altaweel, M ;
Aiello, LP ;
Bressler, NM ;
D'Amico, DJ ;
Goldbaum, M ;
Guyer, DR ;
Katz, B ;
Patel, M ;
Schwartz, SD .
OPHTHALMOLOGY, 2005, 112 (10) :1747-1757
[3]   A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment [J].
Daniels, DA ;
Chen, H ;
Hicke, BJ ;
Swiderek, KM ;
Gold, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15416-15421
[4]   THE CHARACTERIZATION OF P53 BINDING PHAGE ISOLATED FROM PHAGE PEPTIDE DISPLAY LIBRARIES [J].
DANIELS, DA ;
LANE, DP .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (04) :639-652
[5]   Antiviral agents active against influenza A viruses [J].
De Clercq, Erik .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) :1015-1025
[6]   Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy [J].
de Jong, JC ;
van Nieuwstadt, AP ;
Kimman, TG ;
Loeffen, WLA ;
Bestebroer, TM ;
Bijlsma, K ;
Osterhaus, ADME ;
Claas, ECJ .
VACCINE, 1999, 17 (11-12) :1321-1328
[7]   Peptide-mediated interference with influenza A virus polymerase [J].
Ghanem, Alexander ;
Mayer, Daniel ;
Chase, Geoffrey ;
Tegge, Werner ;
Frank, Ronald ;
Kochs, Georg ;
Garcia-Sastre, Adolfo ;
Schwemmle, Martin .
JOURNAL OF VIROLOGY, 2007, 81 (14) :7801-7804
[8]   One-step purification and refolding of recombinant photoprotein aequorin by immobilized metal-ion affinity chromatography [J].
Glynou, K ;
Ioannou, PC ;
Christopoulos, TK .
PROTEIN EXPRESSION AND PURIFICATION, 2003, 27 (02) :384-390
[9]   The effect of electrochemical functionalization of Ti-alloy surfaces by aptamer-based capture molecules on cell adhesion [J].
Guo, Ke-Tai ;
Scharnweber, Dieter ;
Schwenzer, Bernd ;
Ziemer, Gerhard ;
Wendel, Hans P. .
BIOMATERIALS, 2007, 28 (03) :468-474
[10]   Aptamers in the virologists' toolkit [J].
James, William .
JOURNAL OF GENERAL VIROLOGY, 2007, 88 :351-364